Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

Novo Nordisk Pharma Operations A/S

Closing information (x1000 SEK)

Closing information 2021/12 2020/12 2019/12
Turnover 135,643 Less Arrow 106,855 More Arrow 113,199
Earnings before taxes 6,048 Less Arrow 5,037 More Arrow 5,404
Total assets 97,451 Less Arrow 73,771 More Arrow 78,104
Current assets 82,297 Less Arrow 65,477 Less Arrow 61,791
Current liabilities 58,439 Less Arrow 49,653 More Arrow 53,422
Equity capital 28,245 Less Arrow 23,454 Less Arrow 20,070
- share capital 688 Less Arrow 675 More Arrow 698
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2021/12 2020/12 2019/12
Solvency 29.0% More Arrow 31.8% Less Arrow 25.7%
Turnover per employee
Profit as a percentage of turnover 4.5% More Arrow 4.7% More Arrow 4.8%
Return on assets (ROA)
Current ratio 140.8% Less Arrow 131.9% Less Arrow 115.7%
Return on equity (ROE) 21.4% More Arrow 21.5% More Arrow 26.9%
Change turnover 26,726 Less Arrow -2,489 More Arrow 27,490
Change turnover % 25% Less Arrow -2% More Arrow 32%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2021/12 2020/12 2019/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.